Currently, the typical drug-based regimen for pattern hair loss is either minoxidil and/or finasteride -- or possibly dutasteride.   A caveat with all current drug-based options is the potential for negative side effects.  Alternatively, in the past few years a series of naturally-based hair loss treatments have been developed containing active compounds and phytochemicals.  These generally offer an excellent safety profile, however, with rare exception, they remain largely unsupported by peer-reviewed data.

For people concerned about hair loss, many myths and half-truths abound, but useful information can be difficult to put your hands on. Therefore, an objective overview of pattern hair loss is desirable.  

In healthy well-nourished males and females the most common form of hair loss is androgenetic alopecia (AGA), also known as pattern hair loss. The disorder affects approximately 40 million American men.  It may be a shock to learn that common pattern hair loss affects 20 million American women. The difference between the genders is that a woman suffering hair loss usually retains her juvenile hairline but experiences loss of density behind the leading edge. In men, a distinct pattern manifests where the frontal hair line recedes at the same time that a thinning zone expands from the posterior crown. In more pronounced cases, these zones meet and the person is said to be clinically bald.

In the past fifteen years, HairGenesis® has gone through four significant formulation improvements.  

Today, Generation IV HairGenesis® represents the state of the art in naturally derived hair loss treatment 

methodology.  One of the most important features associated with the new formula is its dual-mechanism

design and deployment.